Bank of America
TYRA icon

Bank of America’s Tyra Biosciences TYRA Stock Holding History

Bank of America’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-40,000
Closed -$643K – 7952
2023
Q1 		$643K Buy
+40,000
New +$476K ﹤0.01% 5201

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Bank of America's TYRA Position: Q1 2026 in Review

Bank of America increased its Tyra Biosciences (TYRA) stake by 448% in Q1 2026, buying an estimated $5.56M and bringing the position to 209,922 shares worth $8.04M. The position accounts for ﹤0.01% of the portfolio, ranked #3126.

Bank of America first reported a position in TYRA in Q3 2021 and has held it in 19 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Bank of America held 209,922 shares of Tyra Biosciences worth $8.04M as of Q1 2026.
  • Bank of America bought 171,612 Tyra Biosciences shares in Q1 2026, an estimated $5.56M.
  • Tyra Biosciences made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3126 holding.
  • Bank of America first reported a position in Tyra Biosciences in Q3 2021 and has held it in 19 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.